EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access · CC BY-NC 4.0

Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)

Abhinav Vasudevan iD, Danny Con iD, Peter De Cruz iD, Miles P Sparrow iD, Antony B Friedman iD, Mayur Garg, Soleiman Kashkooli, Peter R Gibson, Daniel R van Langenberg iD

Alimentary Pharmacology & Therapeutics · 2024-02 · 59 (4) · 504-514

DOI: 10.1111/apt.17831 ↗

At a glance

Randomisierte kontrollierte Studie in Alimentary Pharmacology & Therapeutics, published online on 2023-12-14. Written by Abhinav Vasudevan and 8 co-authors. Institution: Department of Gastroenterology and Hepatology, Eastern Health, Box Hill, Victoria, Australia. Major MEDLINE topics: Azathioprine, Inflammatory Bowel Diseases, Purines, Sulfhydryl Compounds. Cited 16 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Thiopurines are established treatments for inflammatory bowel disease (IBD), yet concerns remain regarding their safety.

Aim

To evaluate the use of thiopurine‐allopurinol combination therapy compared to standard thiopurine therapy in IBD.

Methods

We performed a multicentre, randomised, placebo‐controlled trial to compare the efficacy and safety of thiopurine‐allopurinol versus thiopurine with placebo for adults commencing a thiopurine for IBD. Patients had active disease at baseline; dosing of therapy was based on a pre‐specified regimen and subsequent metabolites. The primary outcome was the proportion of patients achieving a composite of symptomatic disease activity remission (Harvey Bradshaw Index

Subjects

MeSH terms (MEDLINE)

AzathioprineInflammatory Bowel DiseasesPurinesSulfhydryl CompoundsAdultHumansFemaleMiddle AgedMaleAllopurinolMercaptopurineImmunosuppressive AgentsTreatment OutcomeDrug Therapy, CombinationImmunologic Factors

Substances

AzathioprineAllopurinolMercaptopurineImmunosuppressive Agents2-mercaptopurineImmunologic FactorsPurinesSulfhydryl Compounds

Authors and institutions

  • Department of Gastroenterology and Hepatology, Eastern Health, Box Hill, Victoria, Australia.
  • Monash University, Eastern Health Clinical School, Box Hill, Victoria, Australia.
  • Department of Gastroenterology, The Austin Hospital, Melbourne, Victoria, Australia.
  • Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia.
  • Department of Gastroenterology, Northern Health, Epping, Victoria, Australia.

ORCID profiles: Abhinav Vasudevan, Danny Con, Peter De Cruz, Miles P Sparrow, Antony B Friedman, Daniel R van Langenberg

Cite

APA

Vasudevan, A., Con, D., De Cruz, P., Sparrow, M. P., Friedman, A. B., Garg, M., Kashkooli, S., Gibson, P. R., & van Langenberg, D. R. (2024). Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary Pharmacology & Therapeutics, 59(4), 504-514. https://doi.org/10.1111/apt.17831

Vancouver

Vasudevan A, Con D, De Cruz P, Sparrow MP, Friedman AB, Garg M, et al. Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary Pharmacology & Therapeutics. 2024;59(4):504-514. doi:10.1111/apt.17831

BibTeX
@article{Vasudevan2024,
  author = {Vasudevan, Abhinav and Con, Danny and De Cruz, Peter and Sparrow, Miles P and Friedman, Antony B and Garg, Mayur and Kashkooli, Soleiman and Gibson, Peter R and van Langenberg, Daniel R},
  title = {Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {59},
  number = {4},
  pages = {504--514},
  doi = {10.1111/apt.17831}
}
Start for free →